Donor-derived cell-free DNA predicted allograft rejection and severe microvascular inflammation in kidney transplant recipients
IntroductionThe aim of this study is to investigate the clinical validity of donor-derived cell-free DNA (dd-cfDNA) in comparison with that of donor specific anti-HLA antibody (DSA) for predicting biopsy-proven rejection (BPR)and severe microvascular i…